This presentation is the property of its rightful owner.
Sponsored Links
1 / 28

Фармакоэкономические аспекты лечения деменции PowerPoint PPT Presentation


  • 120 Views
  • Uploaded on
  • Presentation posted in: General

Фармакоэкономические аспекты лечения деменции. С.К. Зырянов Профессор кафедры клинической фармакологии РНИМУ им. Н.И. Пирогова г. Москва, 07.12.2011 г. Структура летальности в мире. WHO, 2011. Упущенная выгода (мировая экономика, прогноз на 2011-2030 г.г.).

Download Presentation

Фармакоэкономические аспекты лечения деменции

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


7076895

..

. ..

. , 07.12.2011 .


7076895

WHO, 2011


2011 2030

( , 2011-2030 ..)

The global economic burden of non-communicable diseases. A report by the World Economic Forum and the Harvard School of Public Health. September, 2011


7076895

(1)

1%

World Alzheimer Report, 2010


7076895

(2)

World Alzheimer Report, 2010


7076895

2010-2020 ..

.. . 2001; .. ., 2009


7076895

()

5.5%

4.4%

7.7%

55.6%

12.2%

14.5%

Alzheimers Association, 2007

Selkoe DJ. Sci Am 1992;267:97103


7076895

,

,

  • ,

2001

(). Disease Control Priority Project; http://www.dcp2.org/pubs/GBD/3/Table/3.12


7076895

  • , ,

    • 6% , ,

Jnnson L .Int J Geriat Psychiatry 2006;21:44959


7076895

()

  • , ,


7076895

  • , 1

  • , , 2

  • :

  • - 60.8%, 21.0%3 19%4 ,

  • - 28.2%, 9.7%3 12%4 ,

  • , ,

  • ,

1. Imbimbo BP. CNSDrugs2001;15:37590

2. Inglis F. Int J Clin Pract Suppl 2002;127:4563

3. Bullock R .Curr Med Res Opin 2005;21:131727

4. Reminyl Product Monograph (http://www.janssen-ortho.com/JOI/pdf_files/Reminyl_E.pdf)


7076895

-

per os

.

80

20

40

60

100

,

Keith and Kane J Clin Psychiatry 2003; 64: 1308-1315.


7076895

75%

50%

25%

  • 15 25% ( , , )

  • 2 75%

!

Keith and Kane J Clin Psychiatry 2003; 64: 1308-1315

Keith and Kane J Clin Psychiatry 2003; 64: 1308-1315.


7076895

  • , 7 1

  • 4.5 , 2

1. Fitzpatrick AL, .J Neurol Sci. 2005;229-230:439

2. Singh G, .J Am Geriatr Soc. 2005;53:126970


7076895

  • 73% 1

  • , , 2

22%

73%

5%

1. Alzheimers Association and National Alliance for Caregiving, 2004 National Survey

2. Sink KM .J Am Geriatr Soc 2006;54:796803


7076895

25

20

15

10

5

0

0

6

12

18

24

()

9.5 /24

6 , , 2

(/)

9.5 /24

(AUC), 6 2

(12 /)*

*

.


7076895

3 ,

12 /

9.5 /24

25

23.1%

20

17.0%

15

, (%)

10

7.2%

6.2%

5.0%

5

3.3%

0

Winblad B .Int J Geriatr Psychiatry 2007;22:45667


7076895

95.9%

% , IDEAL,

64.4%

n = 250

9.5/24

n = 241

Winblad B, .Int J Geriatr Psychiatry 2007;22:45667


7076895

: -

- ()


7076895

- :


7076895

,

  • IDEAL (24 28- , 250 , 256 , 281 )

  • MMSE ADL

Nagy B., Brennan A., Brandtmller A. et al. Int J Geriatr Psychiatry, 2010


7076895

,

Nagy B., Brennan A., Brandtmller A. et al. Int J Geriatr Psychiatry, 2010


7076895

- :


7076895

  • ( , )

  • - EA

.. , .. , 2011 ( )


7076895

*Mucha L. et al. J Manag Care Pharm. 2008;14(5):451-61

**Winblad B. et al. Int J Geriatr Psychiatry 2007; 22: 485491

***Krger E. et al. Drug Aging 2010; 27 (8): 663-675


7076895

www.grls.rosminzdrav.ru ( 20.09.2011 .)


7076895

(CER)

.. , .. , 2011 ( )


7076895

  • , (), (IR ER),


  • Login